Recall – Dose effect criteria altered by software error

Company: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Date of Enforcement Report: 5/11/2022
Class II

PRODUCT

Azurion systems with software release R1.x

Recall Number:

Z-0886-2022

REASON

In the Azurion system, the user can add a new study to a patient by selecting the option Add Study . The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.

RECALLING FIRM/MANUFACTURER

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. on 5/26/2021. FDA Mandated

VOLUME OF PRODUCT IN COMMERCE

720 systems

DISTRIBUTION

U.S. Nationwide and International

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.